Health ❯ Healthcare ❯ Medical Research

Cancer Treatment

Immunotherapy Pancreatic Cancer mRNA Vaccines Breast Cancer Prostate Cancer Melanoma Glioblastoma Lung Cancer Chemotherapy Clinical Trials

4 ARTICLES

last wk.

Five‑Session SBRT Shows Comparable Long‑Term Control to Prostatectomy With Fewer Urinary and Sexual Side Effects

PACE‑A’s eight‑year randomized results strengthen support for five‑session image‑guided SBRT as a non‑surgical curative option without proving it superior

4 ARTICLES

last wk.

ASTRO 2026 to Spotlight Phase 3 Trial Results and Mayo Clinic First‑in‑Human Minibeam Data

5 ARTICLES

3w ago

Platinum Chemotherapy Leaves Extensive Mutational Footprint in Children's Livers

8 ARTICLES

4w ago

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

9 ARTICLES

4w ago

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

7 ARTICLES

last mo.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

3 ARTICLES

last mo.

Adelaide Team Wins $240,000 to Rework How Radiotherapy Targets Brain Tumours

5 ARTICLES

last mo.

Moderna and Merck Say Personalized mRNA Vaccine Met Phase III Endpoints in Resected Melanoma

21 ARTICLES

last mo.

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

5 ARTICLES

last mo.

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

11 ARTICLES

last mo.

Merck and Moderna Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

26 ARTICLES

last mo.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

11 ARTICLES

last mo.

Moderna and Merck Report First Phase III Win for an mRNA Cancer Vaccine

119 ARTICLES

last mo.

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

22 ARTICLES

last mo.

Moderna and Merck Report Positive Phase‑3 Result for Personalized mRNA Melanoma Vaccine

5 ARTICLES

last mo.

Personalized mRNA Vaccine Shows Phase 3 Benefit in High‑Risk Melanoma

3 ARTICLES

2mo ago

DR5–Lig3 Feedback Loop Explains Why MSI Colorectal Tumors Respond to Immunotherapy

4 ARTICLES

3mo ago

Selected Lung Transplants Linked to Higher One-Year Survival in Stage 4 Lung Cancer

5 ARTICLES

3mo ago

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

3 ARTICLES

3mo ago

Experimental UCalgary CAR T Therapy GCAR1 Shrinks Rare Solid Tumours

Cancer Treatment

Five‑Session SBRT Shows Comparable Long‑Term Control to Prostatectomy With Fewer Urinary and Sexual Side Effects

ASTRO 2026 to Spotlight Phase 3 Trial Results and Mayo Clinic First‑in‑Human Minibeam Data

Platinum Chemotherapy Leaves Extensive Mutational Footprint in Children's Livers

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Adelaide Team Wins $240,000 to Rework How Radiotherapy Targets Brain Tumours

Moderna and Merck Say Personalized mRNA Vaccine Met Phase III Endpoints in Resected Melanoma

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

Never miss stories about

Cancer Treatment

Merck and Moderna Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Moderna and Merck Report First Phase III Win for an mRNA Cancer Vaccine

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

Moderna and Merck Report Positive Phase‑3 Result for Personalized mRNA Melanoma Vaccine

Personalized mRNA Vaccine Shows Phase 3 Benefit in High‑Risk Melanoma

DR5–Lig3 Feedback Loop Explains Why MSI Colorectal Tumors Respond to Immunotherapy

Selected Lung Transplants Linked to Higher One-Year Survival in Stage 4 Lung Cancer

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

Experimental UCalgary CAR T Therapy GCAR1 Shrinks Rare Solid Tumours

Never miss stories about

Cancer Treatment